| Clinical features and outcomes of takotsubo (stress) cardiomyopathy C Templin, JR Ghadri, J Diekmann, LC Napp, DR Bataiosu, ... New England Journal of Medicine 373 (10), 929-938, 2015 | 2650 | 2015 |
| Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents M Pfisterer, HP Brunner-La Rocca, PT Buser, P Rickenbacher, P Hunziker, ... Journal of the american College of Cardiology 48 (12), 2584-2591, 2006 | 1819 | 2006 |
| Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents A Kastrati, J Mehilli, J Pache, C Kaiser, M Valgimigli, H Kelbæk, ... New England Journal of Medicine 356 (10), 1030-1039, 2007 | 1377 | 2007 |
| Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis T Palmerini, G Biondi-Zoccai, D Della Riva, C Stettler, D Sangiorgi, ... The Lancet 379 (9824), 1393-1402, 2012 | 1107 | 2012 |
| Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque PW Serruys, HM García-García, P Buszman, P Erne, S Verheye, ... Circulation 118 (11), 1172-1182, 2008 | 604 | 2008 |
| Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction A Kastrati, A Dibra, C Spaulding, GJ Laarman, M Menichelli, M Valgimigli, ... European heart journal 28 (22), 2706-2713, 2007 | 536 | 2007 |
| Perioperative myocardial injury after noncardiac surgery: incidence, mortality, and characterization C Puelacher, G Lurati Buse, D Seeberger, L Sazgary, S Marbot, ... Circulation 137 (12), 1221-1232, 2018 | 501 | 2018 |
| Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts … C Kaiser, HP Brunner-La Rocca, PT Buser, PO Bonetti, S Osswald, ... The Lancet 366 (9489), 921-929, 2005 | 474 | 2005 |
| A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease A Schömig, A Dibra, S Windecker, J Mehilli, J Suárez de Lezo, C Kaiser, ... Journal of the American College of Cardiology 50 (14), 1373-1380, 2007 | 431 | 2007 |
| Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial RV Jeger, A Farah, MA Ohlow, N Mangner, S Möbius-Winkler, ... The Lancet 392 (10150), 849-856, 2018 | 398 | 2018 |
| Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a … M Haude, H Ince, A Abizaid, R Toelg, PA Lemos, C Von Birgelen, ... The Lancet 387 (10013), 31-39, 2016 | 393 | 2016 |
| Clinical outcomes with bioabsorbable polymer-versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis T Palmerini, G Biondi-Zoccai, D Della Riva, A Mariani, M Sabaté, ... Journal of the American College of Cardiology 63 (4), 299-307, 2014 | 345 | 2014 |
| Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial L Räber, Y Ueki, T Otsuka, S Losdat, JD Häner, J Lonborg, G Fahrni, ... Jama 327 (18), 1771-1781, 2022 | 344 | 2022 |
| Drug-eluting versus bare-metal stents in large coronary arteries C Kaiser, S Galatius, P Erne, F Eberli, H Alber, H Rickli, G Pedrazzini, ... New England Journal of Medicine 363 (24), 2310-2319, 2010 | 320 | 2010 |
| Long-term prognosis of patients with Takotsubo syndrome JR Ghadri, K Kato, VL Cammann, S Gili, S Jurisic, D Di Vece, A Candreva, ... Journal of the American College of Cardiology 72 (8), 874-882, 2018 | 315 | 2018 |
| Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a … T Pilgrim, D Heg, M Roffi, D Tüller, O Muller, A Vuilliomenet, S Cook, ... The Lancet 384 (9960), 2111-2122, 2014 | 298 | 2014 |
| Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis T Palmerini, G Biondi-Zoccai, D Della Riva, A Mariani, M Sabaté, ... Journal of the American College of Cardiology 62 (6), 496-504, 2013 | 274 | 2013 |
| Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials G De Luca, MT Dirksen, C Spaulding, H Kelbaek, M Schalij, L Thuesen, ... Archives of internal medicine 172 (8), 611-621, 2012 | 244 | 2012 |
| Happy heart syndrome: role of positive emotional stress in takotsubo syndrome JR Ghadri, A Sarcon, J Diekmann, DR Bataiosu, VL Cammann, S Jurisic, ... European heart journal 37 (37), 2823-2829, 2016 | 233 | 2016 |
| A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry JR Ghadri, VL Cammann, S Jurisic, B Seifert, LC Napp, J Diekmann, ... European journal of heart failure 19 (8), 1036-1042, 2017 | 213 | 2017 |
